Click to search

STAT1 acts as a tumor promoter for leukemia development.

Authors

Kovacic B1, Stoiber D, Moriggl R, Weisz E, Ott RG, Kreibich R, Levy DE, Beug H, Freissmuth M, Sexl V.
Author information
  • 1Department of Pharmacology, Medical University of Vienna (MUW), Vienna A-1090, Austria.

Journal

Cancer Cell. 2006 Jul;10(1):77-87.

Affiliation

Comment in

Abstract

The tumor suppressor STAT1 is considered a key regulator of the surveillance of developing tumors. Here, we describe an unexpected tumor-promoting role for STAT1 in leukemia. STAT1(-/-) mice are partially protected from leukemia development, and STAT1(-/-) tumor cells induce leukemia in RAG2(-/-) and immunocompetent mice with increased latency. The low MHC class I protein levels of STAT1(-/-) tumor cells enable efficient NK cell lysis and account for the enhanced tumor clearance. Strikingly, STAT1(-/-) tumor cells acquire increased MHC class I expression upon leukemia progression. These findings define STAT1 as a tumor promoter in leukemia development. Furthermore, we describe the upregulation of MHC class I expression as a general mechanism that allows for the escape of hematopoietic malignancies from immune surveillance.

PMID

16843267 [PubMed - indexed for MEDLINE]
Elsevier Science: Free full text
Standard PubMed